February 17, 2022  |  Macro

[Report] As China beats back Omicron, longer-term questions emerge

Over the past two months, investors have zeroed in on the idea that the latest, highly transmissible Omicron variant of COVID-19 would severely test China’s tried-and-true pandemic playbook and zero-tolerance approach.

This is premium content. Subscribe for access, or login below.

Previous report: